Seven years ago, one of Generation Bio’s scientific founders couldn’t convince any top-tier journals to publish his research.
Now, the same company earned itself a presenting spot at this week’s J.P. Morgan Healthcare Conference, after it raised more than $200 million in two years.
About the Author Reprints
